Cargando…
OR19-2 Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) with Low and High Dose of Triiodothyronine: an Animal Model of Metabolic Syndrome with HFpEF
INTRODUCTION: Low levels of triiodothyronine (T3) are common in patients with heart failure (HF). It has been proposed that the decreased levels of T3 contribute to metabolic and cardiac dysfunction in HF. We aimed to evaluate the effects of treatment with low dose and high dose of T3 in an animal m...
Autores principales: | Almeida-Coelho, João, Barez-Lopez, Soledad, Borges-Canha, Marta, Carvalho, Davide, Conceição, Glória, Falcão-Pires, Inês, Fontoura, Dulce, Gonçalves, Alexandre, Grijota-Martinez, Carmen, Leite, Ana Rita, Leite, Sara, Leite-Moreira, Adelino, Lourenço, André, Miranda-Silva, Daniela, Obregon, Maria Jesús, Vale, Catarina, Von-Hafe, Madalena, Neves, João Sérgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625197/ http://dx.doi.org/10.1210/jendso/bvac150.1657 |
Ejemplares similares
-
Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022) -
Focus on HFpEF in heart failure
por: He, Chunhui, et al.
Publicado: (2022) -
Similarities and Differences Between HFmrEF and HFpEF
por: Li, Peixin, et al.
Publicado: (2021) -
New aspects in cardiorenal syndrome and HFpEF
por: Méndez, Ana Belén, et al.
Publicado: (2022) -
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
por: Grossekettler, Leonie, et al.
Publicado: (2020)